TickerFactsScreenerDevelopers

CRESCENT BIOPHARMA, INC. (CBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$8.24M2016: -$29.73M2017: -$29.77M2018: -$43.33M2019: -$51.98M2020: -$39.24M2021: -$57.49M2022: -$46.46M2023: -$34.88M2024: -$31.10M2025: -$71.53M-$71.53M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$71.53M-130.0%
2024-$31.10M+10.8%
2023-$34.88M+24.9%
2022-$46.46M+19.2%
2021-$57.49M-46.5%
2020-$39.24M+24.5%
2019-$51.98M-20.0%
2018-$43.33M-45.6%
2017-$29.77M-0.1%
2016-$29.73M-260.7%
2015-$8.24M—